Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Cardiotoxicity 4Sarcoma 3Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Localized Extraskeletal Ewing Sarcoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Ganglioneuroblastoma 1Burkitt Lymphoma 1

Interventions

Methotrexate 10Cyclophosphamide 10Cytarabine 9merphos 7Vincristine 7Asparaginase 7Specimen Handling 6Methylprednisolone 6Hydrocortisone 6Daunorubicin 6pegaspargase 5fludarabine phosphate 5Prednisone 5Mercaptopurine 5fludarabine 4calaspargase pegol 4Whole-Body Irradiation 4Prednisolone 4Mycophenolic Acid 4Leucovorin 4Filgrastim 4Dexamethasone 4Busulfan 4Biopsy 4prednylidene 3dexamethasone acetate 3dexamethasone 21-phosphate 3deltacortene 3azathiopurine 3auricularum 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Biphenotypic, Acute × Dexrazoxane × Clear all
NCT03007147 2026-05-04

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Active not recruiting
475 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡